Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.

As medications like 'Wegovy' and 'Ozempic' (GLP‑1 receptor agonists) become more common in weight‑loss strategies, US ...

NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new ...

New retirees might enter a different environment than their predecessors — the economy or market might have changed slightly ...

Whether it’s treating hypertension, diabetes, heart disease, or conditions, the right detox can do wonders for your daily health & happiness.

The FDA announced on Thursday that Juul can keep its products on the market, after the company submitted studies that claim ...